Combined measurement of serum tumor markers in patients with hepatocellular carcinoma

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 4, Issue 2

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

197

HTML

1606

Tables (1-5)

147

Sum=1950

Apr 15, 1998 (publication date) through Jul 31, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Reports

World J Gastroenterol. Apr 15, 1998; 4(2): 181-182
Published online Apr 15, 1998. doi: 10.3748/wjg.v4.i2.181

Table 1 The serum levels of AFP, AFU and SA among patients in the three groups (x ± s)

^bP < 0.01, compared with controls,

^dP < 0.01, compared with cirrhosis.

Citation: Cai WX, Zheng H, Sheng J, Ye QL. Combined measurement of serum tumor markers in patients with hepatocellular carcinoma. World J Gastroenterol 1998; 4(2): 181-182
URL: https://www.wjgnet.com/1007-9327/full/v4/i2/181.htm
DOI: https://dx.doi.org/10.3748/wjg.v4.i2.181